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ABSTRACT The chicken gastrointestinal tract is richly populated by commensal
bacteria that fulﬁll various beneﬁcial roles for the host, including helping to resist
colonization by pathogens. It can also facilitate the conjugative transfer of multidrug
resistance (MDR) plasmids between commensal and pathogenic bacteria which is a
signiﬁcant public and animal health concern as it may affect our ability to treat bac-
terial infections. We used an in vitro chemostat system to approximate the chicken
cecal microbiota, simulate colonization by an MDR Salmonella pathogen, and exam-
ine the dynamics of transfer of its MDR plasmid harboring several genes, including
the extended-spectrum beta-lactamase blaCTX-M1. We also evaluated the impact of
cefotaxime administration on plasmid transfer and microbial diversity. Bacterial com-
munity proﬁles obtained by culture-independent methods showed that Salmonella
inoculation resulted in no signiﬁcant changes to bacterial community alpha diversity
and beta diversity, whereas administration of cefotaxime caused signiﬁcant altera-
tions to both measures of diversity, which largely recovered. MDR plasmid transfer
from Salmonella to commensal Escherichia coli was demonstrated by PCR and whole-
genome sequencing of isolates puriﬁed from agar plates containing cefotaxime.
Transfer occurred to seven E. coli sequence types at high rates, even in the absence
of cefotaxime, with resistant strains isolated within 3 days. Our chemostat system
provides a good representation of bacterial interactions, including antibiotic resis-
tance transfer in vivo. It can be used as an ethical and relatively inexpensive ap-
proach to model dissemination of antibiotic resistance within the gut of any animal
or human and reﬁne interventions that mitigate its spread before employing in vivo
studies.
IMPORTANCE The spread of antimicrobial resistance presents a grave threat to
public health and animal health and is affecting our ability to respond to bacterial
infections. Transfer of antimicrobial resistance via plasmid exchange is of particular
concern as it enables unrelated bacteria to acquire resistance. The gastrointestinal
tract is replete with bacteria and provides an environment for plasmid transfer be-
tween commensals and pathogens. Here we use the chicken gut microbiota as an
exemplar to model the effects of bacterial infection, antibiotic administration, and
plasmid transfer. We show that transfer of a multidrug-resistant plasmid from the
zoonotic pathogen Salmonella to commensal Escherichia coli occurs at a high rate,
even in the absence of antibiotic administration. Our work demonstrates that the in
vitro gut model provides a powerful screening tool that can be used to assess and
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reﬁne interventions that mitigate the spread of antibiotic resistance in the gut be-
fore undertaking animal studies.
KEYWORDS Escherichia coli, Salmonella, antimicrobial resistance, enteric pathogens,
horizontal gene transfer, plasmids
Chickens (Gallus gallus) are a source of human infection by zoonotic pathogens suchas Salmonella enterica, Campylobacter spp., and Escherichia coli (1, 2). The chicken
cecum appears to be a rich source of bacteria, including pathogens (3). The gut
microbiota helps protect chickens from colonization by pathogens (4), but this can be
weakened through administration of antibiotics that perturb the gut bacterial commu-
nity, resulting in steep declines in the abundance and diversity of gut bacteria (5–11).
Antibiotic administration can also select for antimicrobial resistance (AMR) genes,
which may be carried by commensals or pathogens (4, 5, 12). The transfer of AMR genes
between bacteria and the spread of resistance have implications for human and animal
health (13, 14). Dissemination of resistance via plasmids harboring multiple AMR genes,
including extended-spectrum beta-lactamases (ESBLs), is of particular therapeutic rel-
evance and has been demonstrated between different bacterial genera on a single farm
(15) and between animal and human strains of E. coli (16, 17).
The potential for dissemination of AMR via plasmid conjugation in the chicken cecal
microbiota has not been fully deﬁned. Various in vitro chemostat models have been
developed to investigate the gut microbiota of humans and animals (18, 19). These
models seek to simulate the physiological conditions encountered in the gut (e.g., pH
and temperature) and employ culture media that support diverse bacterial communi-
ties, resembling those found in vivo. The models vary in complexity, with some
consisting of a single batch fermentation vessel run for 24 to 48 h, whereas others use
one or more vessels in series and employ a continuous ﬂow system to introduce fresh
media, allowing the system to be run for days or weeks; most monitor changes in a
handful of bacteria using mainly culture-based methods (18, 19). Chemostats provide
useful screening tools to examine the effects of interventions on the microbiota under
controlled experimental conditions without the ethical restrictions associated with
human and animal trials. Such models have been used to investigate the impact of
antibiotics on proliferation of Clostridium difﬁcile in a human gut model (20), the
transfer of AMR gene-harboring plasmids from avian E. coli to a limited number of
human E. coli clones in a human gut model (17), the production of metabolites such as
short-chain fatty acids in human, chicken, and pig microbiota (21, 22), and the impact
of dietary elements on human microbiota (23, 24).
In this study, we report the development of an in vitro chemostat system that aims
to approximate the chicken cecal microbiota and use it to demonstrate the effect
of infection of the chicken with a multidrug-resistant (MDR) Salmonella and ensuing
antibiotic administration. Salmonella colonization was simulated by inoculation of a
strain of Salmonella enterica serovar Typhimurium, carrying the MDR IncI1 plasmid
pIFM3844 that harbors three AMR genes, including the ESBL gene blaCTX-M1, and that
readily transfers between bacteria of the same and related species on farms (15).
Samples were withdrawn at regular intervals over the time period that the chemostat
vessels were run and analyzed for changes in total bacterial diversity using culture-
independent methods, as well as for enumeration of selected bacteria by culture. An
important aspect of this study was to determine whether the presence of a zoonotic
pathogen in the chicken ceca harboring an MDR plasmid results in transfer and
proliferation of this plasmid in commensal bacteria that may result in a signiﬁcant
increase in the reservoir of resistant bacteria and their possible transfer through the
food chain to affect humans. The results have a wider implication in that they
demonstrate how MDR plasmids may proliferate and disseminate in the gut environ-
ment of any animal, including humans.
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RESULTS
Establishing the in vitro gut model and cecal microbiota proﬁling. The gut
model was seeded with cecal samples collected from Salmonella-free chickens reared
under experimental conditions in a biosecure environment. To assess the total bacterial
diversity using culture-independent methods, microbial proﬁling by ampliﬁcation and
pyrosequencing of the 16S rRNA gene was performed on the seeded cecal samples, and
examined using QIIME (25). This showed that the phylum Firmicutes dominated in these
cecal samples (average relative abundance of 95.17%), comprised mainly of members
of the family Ruminococcaceae (average relative abundance of 56.81%). Other bacterial
phyla were present at low abundance, as were reads unassigned to any bacteria
(~0.42%; see Tables S1 and S2 in the supplemental material).
Microbial proﬁles of the total bacterial population were also generated from sam-
ples withdrawn at the different time points for each vessel in the four gut model
experiments performed after seeding with cecal contents. The culture-independent
methods examined these bacterial communities, and the microbial proﬁles obtained
from the four experiments were summarized as the relative abundance of sequences
taxonomically classiﬁed to family or next highest possible resolution level (order, class,
or phylum) (Table S3). Similar results were obtained in the four experiments (see
below), with microbial proﬁles obtained in experiment 4 shown in Fig. 1 as an exemplar
of the results obtained. In all vessels, a diverse bacterial population was present, which
altered over time and in response to cefotaxime administration (Fig. 1). Importantly, no
single taxon was seen to dominate. To identify statistically signiﬁcant changes in the
bacterial communities, the 16S rRNA metagenomic data from all four experiments were
analyzed using QIIME and structured to allow comparison by experiment number, time
FIG 1 Microbial proﬁles obtained in experiment 4 showing responses to cefotaxime (CTX) administration and time point. Populations are presented as relative
abundance of sequences taxonomically classiﬁed to family or the next highest possible resolution level (order, class, or phylum), and the isolates are identiﬁed
by the vessel (V) number and day of isolation (D). The data presented in this ﬁgure are also given in Table S3 in the supplemental material.
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point, cefotaxime administration, and Salmonella inoculation. The results showed a
signiﬁcant but small difference in microbial community composition between experi-
ments (P  0.002 and R2  0.094 by Adonis analysis). These differences arose from
dissimilar abundances in the input cecal material. Indeed, of the 18 operational
taxonomic units (OTUs) that were signiﬁcantly different in experiments, 8 were not
detected in one or more cecal preparations. Importantly, there were no signiﬁcant
differences between experiments in the alpha diversity indices estimating bacterial
species richness (Chao1, P  0.789) or estimating bacterial community evenness
(Shannon, P  0.425) (Table 1 and Fig. S1), indicating reproducibility and consistency
in the capability of the in vitro system to maintain diverse bacterial populations.
There was, however, a signiﬁcant change in the bacterial community over the course
of the experiment (P  0.001 and R2  0.359 by Adonis analysis) and signiﬁcant
differences in the Chao1 (P  0.001) and Shannon (P  0.001) alpha diversity indices
(Table 1 and Fig. S1). At days 1 and 2, there was an increase in alpha diversity indices
above that of the input ceca, but after day 4, both indices decreased below initial levels,
and these indices stabilized from day 6 onwards, with little change in the alpha and
beta diversity in the bacterial community thereafter (Fig. 2 and Fig. S1). These results
indicated that there was a temporary increase, followed by a decrease in community
richness and abundance, followed by stability in these parameters. Changes in the
bacterial communities during the course of the experiment were further investi-
gated by three-dimensional principal-coordinate analysis of the weighted UniFrac beta
diversity (Fig. 2). The majority of OTUs with a signiﬁcant decrease in abundance were
assigned to taxa (class or family) of obligate anaerobes such as Clostridiales, Lachno-
spiraceae, and Ruminococcaceae, although certain OTUs of Lachnospiraceae in-
creased signiﬁcantly. Other OTUs with a signiﬁcant increase in abundance were mainly
from families of facultative or aerotolerant anaerobes, such as Clostridiaceae, Entero-
coccaceae, and Enterobacteriaceae. The two OTUs from Enterobacteriaceae with a sig-
niﬁcant increase in abundance were not assigned to a genus by the QIIME pipeline;
furthermore, there was no signiﬁcant change in OTUs from the genus Escherichia.
Modeling the impact of Salmonella inoculation on the cecal microbiota. In
experiments 3 and 4, 107 CFU of Salmonella strain B3844 were inoculated into four gut
model vessels per experiment (two vessels at hour 0 and two vessels at hour 21).
Enumeration of the Salmonella by culture showed that it was maintained in all
inoculated vessels at ~104 to 106 CFU/ml for 8 days. Similar results were obtained in
both experiments, and results for experiment 4 are shown in Fig. 3a. The cecal samples
used to inoculate vessels contained no Salmonella detected by culture on Rambach
agar.
Further analysis of the microbial proﬁle data showed no signiﬁcant difference in the
diversities of the bacterial communities between Salmonella-free chickens and those
inoculated with Salmonella at either hour 0 or hour 21, measured by UniFrac beta
diversity (P  0.374 and R2  0.026 by Adonis analysis) (Table 1), nor any signiﬁcant
difference in other diversity indices such as the Chao1 (P  0.956) or Shannon (P 
0.392) alpha diversity (Fig. S1). However, one OTU (family Peptostreptococcaceae) was
TABLE 1 Signiﬁcance in differences between alpha and beta diversity indices for the variables (experiment, time point, Salmonella
inoculation, and cefotaxime administration)
Variable examined
Alpha diversity
Beta diversity (weighted
UniFrac) by Adonis analysis
Statistical test
P value for alpha diversity
index:
P value R2 valueChao1 Shannon
Experiment Kruskal-Wallis 0.789 0.425 0.002 0.094
Time point Kruskal-Wallis 0.001 0.001 0.001 0.359
Salmonella inoculation Kruskal-Wallis 0.956 0.392 0.374 0.026
Cefotaxime administration Mann-Whitney (two-tailed) 0.019 0.001 0.001 0.134
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identiﬁed with a signiﬁcantly increased abundance following Salmonella inoculation.
Three-dimensional principal-coordinate analysis of the weighted UniFrac beta diversity
revealed no clustering of samples by Salmonella administration (Fig. S2).
Modeling the impact of cefotaxime administration on the cecal microbiota.
Microbial proﬁling and QIIME analysis showed that bacterial communities in
cefotaxime-treated vessels showed signiﬁcant decreases in species richness (Chao1
alpha diversity; P  0.019) and community evenness (Shannon alpha diversity; P 
0.001) compared to non-antibiotic-treated vessels (Table 1 and Fig. S1). Furthermore,
bacterial diversity measured by Adonis analysis comparing cefotaxime (CTX)-treated
vessels with nontreated vessels using the weighted UniFrac beta diversity indicated
that there were signiﬁcant changes to the bacterial community after cefotaxime was
administered (P  0.001 and R2  0.134; Table 1). This change in the bacterial
community was distinctly different to that observed in vessels not administered CTX, as
illustrated in the principal-coordinate analysis plots (Fig. 2). Furthermore, following
cefotaxime administration, 10 OTUs were signiﬁcantly more abundant, including 2
Enterococcus OTUs, while 17 OTUs decreased in abundance (Table S4). Alterations in
enterococcal populations were also seen by culture, conﬁrming the microbial proﬁling
data. In experiment 4, prior to cefotaxime administration, there were approximately 104
to 105 CFU/ml enterococci on cefotaxime-containing plates, but after cefotaxime
treatment, this increased to ~108 to 109 CFU/ml (Fig. 3b). Increases in enterococci after
cefotaxime administration were also seen in experiments 2 and 3 (not shown). The
same effect was not observed in the microbial proﬁling or bacterial enumeration data
from the three vessels not treated with cefotaxime (Fig. 3b). As expected, cefotaxime
administration had no effect on Salmonella numbers (Fig. 3a).
Transfer of a multidrug-resistant plasmid from Salmonella to commensal
E. coli. In both experiments 3 and 4, culture on cefotaxime selective plates did not
detect any presumptive E. coli resistant to cefotaxime in the cecal contents or at any
time point in the two vessels to which Salmonella was not added. In experiment 4, on
the third day, cefotaxime-resistant presumptive E. coli bacteria were detected on the
Rambach agar plates supplemented with cefotaxime from two of the four vessels into
FIG 2 Three-dimensional principal-coordinate analysis plot of weighted UniFrac beta diversity. Samples
are colored by time point as indicated in the color key. Samples at the same time point were circled
manually, and the black arrows indicate the progression of time. Cefotaxime addition ( CTX; dashed
encircling) or absence of cefotaxime ( CTX; solid encircling) is shown. PC1, principal coordinate 1.
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FIG 3 Quantitative bacteriology results for experiment 4 showing the number of CFU per milliliter of culture for presumptive
cefotaxime-resistant Salmonella (Rambach agar) (a), enterococci (UTI Brilliance agar) (b), and cefotaxime-resistant E. coli
(Rambach agar) (c). Counts obtained from each of the six vessels employed in the experiment are shown as presented in the
symbol key. Salmonella was inoculated into vessels 3 and 4 at hour 0 and into vessels 5 and 6 at hour 21. Cefotaxime (CTX)
was administered on the second and third day to vessels 2, 4, and 6 as indicated.
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which Salmonella had been inoculated (Fig. 3c). By day 6, cefotaxime-resistant E. coli
bacteria were present in all vessels inoculated with Salmonella and remained present
until the ﬁnal day of the experiment (day 8). Similarly, in experiment 3, cefotaxime-
resistant E. coli bacteria were observed in all vessels containing Salmonella by day 8 (not
shown). Plasmid transfer rates for experiment 4 were calculated by using the endpoint
bacterial enumeration method (26) with day 8 counts and ranged from 2.2  109 to
6.4  1010.
All presumptive Salmonella isolates (n  13) recovered from Rambach agar plates
were veriﬁed as Salmonella by matrix-assisted laser desorption ionization–time of ﬂight
mass spectrometry (MALDI-TOF MS) and were PCR positive for the pIFM3844 plasmid
and the blaCTX-M1 gene it harbors (Table S5). The presumptive enterococcal isolates
(n  6) recovered on day 5 of experiment 4 were veriﬁed as Enterococcus faecium by
MALDI-TOF MS, and all of these isolates were PCR negative for blaCTX-M1 and pIFM3844
(Table S5). The presumptive E. coli isolates recovered from cefotaxime-containing plates
in experiments 3 (n  11 isolates) and 4 (n  23 isolates) were veriﬁed as E. coli by
MALDI-TOF MS (Table S5) and were PCR positive for blaCTX-M1 and pIFM3844 (Table S5).
Presumptive E. coli bacteria recovered from plates without cefotaxime in experiments
3 (n 6 isolates) and 4 (n 12 isolates) were PCR negative for blaCTX-M1 and pIFM3844
(Table S5).
Whole-genome sequencing of commensal E. coli transconjugants. To compare
the commensal E. coli present in the chicken cecal content to transconjugants recov-
ered by culture and to determine whether pIFM3844 had transferred into one or more
different E. coli clones, we performed whole-genome sequencing on 39 isolates from
experiments 3 and 4. Isolates were recovered from plates with cefotaxime (n  28) or
without cefotaxime (n  11). The maximum likelihood tree based on core genome
single nucleotide polymorphisms (SNPs) showed nine subclades of E. coli, which we
have called “clones” due to the high sequence similarity in the core genome between
members of a clone, and these clones represent different E. coli present in the chicken
microbiota in the two experiments (Fig. 4). Each clone was of a different sequence type
(ST); STs were assigned to isolates from ﬁve clones, two clones had STs that were not
represented in the database, and STs for two clones were assigned only provisionally
due to poor sequence quality in one or more multilocus sequence type (MLST) genes
(Table S6). In the phylogenetic tree constructed (Fig. 4), these 39 isolates did not cluster
with the 12 published genomes of E. coli recovered from poultry.
The pIFM3844 plasmid was present in some isolates from clones 3 and 9, but absent
in all isolates from clones 4 and 7 (Fig. 4). For all other clones, pIFM3844 was present
in every isolate sequenced (Fig. 4). Isolates from clone 9 were recovered from experi-
ments 3 and 4, whereas all other clones were recovered from one experiment only. As
summarized in Fig. 4, isolates of the same clone were recovered on different days from
the same vessel (clones 2, 3, 5, and 9) and/or recovered from different vessels of the
same experiment (clones 3, 4, 7, 8, and 9).
The AMR gene content of each sequenced isolate was examined by SeqFinder (27).
The ESBL gene blaCTX-M1 was identiﬁed in all 28 sequenced isolates that were PCR
positive for pIFM3844 and blaCTX-M1, as expected. Although most commensal E. coli
isolates did not harbor any other AMR genes, one isolate carried 11 AMR genes and
three others harbored one additional AMR gene (not shown).
DISCUSSION
We have developed an in vitro chemostat system that aims to simulate the chicken
cecal microbiota and can be used to predict the effect of infection in chickens with
multidrug-resistant Salmonella and ensuing antibiotic administration. To accomplish
this, cecal contents from chickens hatched and reared in biosecure accommodation
were used to ensure the initial absence of Salmonella. Microbial proﬁling of the
uncultured cecal microbiota from these chickens showed it to be dominated by
Firmicutes, whereas members of the phylum Bacteroidetes were absent. N. O. Kaakoush
et al. (28) have classiﬁed the chicken microbiota into enterotypes 1 to 4; the microbiota
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of our biosecure chickens resembled enterotype 1, as it was dominated by Firmicutes.
However, diversity at the family and genus level in our birds was different from that
described for enterotype 1. Unlike many other farm animals, chickens are hatched and
raised without contact with their parents and thus acquire the majority of their
microbiota from the environment, although vertical transmission from the parent to the
offspring (in ovo or from shell contamination) can occur for certain bacteria, including
Salmonella. Thus, the biosecure accommodation would be expected to provide a
considerably cleaner environment than that present on, for example, commercial
broiler chicken farms, thereby limiting the diversity of bacteria available for colonization
of the gut in birds used in our experiments.
Although the in vitro model is a chemostat system that can only be a surrogate of
the chicken gut, it nevertheless enabled culture of a diverse bacterial community,
representative of the gut, for 8 days in a reproducible manner. The bacterial community
did change over this period, as assessed by microbial proﬁling of the uncultured
microbiota, which showed that there was an initial reduction in the overall diversity and
in some OTUs for obligate anaerobes; OTUs for several facultative or aerotolerant
FIG 4 Maximum likelihood phylogenetic tree generated from core genome single nucleotide polymorphisms in RAxML. The tree contains the 39 sequenced
commensal E. coli isolates recovered from gut model experiments 3 (clones 7 and 9) and 4 (clones 1, 2, 3, 4, 5, 6, and 8 and isolate EC38 in clone 9). Salmonella
was inoculated into vessel 3 (V3) and V4 at hour 0 and into vessels V5 and V6 at hour 21. Cefotaxime (CTX) was administered on the second and third day to
vessels V2, V4, and V6. Also included in the tree are 12 reference E. coli isolates from poultry comprising commensal, ESBL-harboring, or avian pathogenic E.
coli (APEC) isolates. The bar indicates 0.008 nucleotide substitutions per position.
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anaerobes increased signiﬁcantly with time. However, importantly, the community
appeared to be stabilizing by day 6 and did not come to be dominated by a single
taxon. The changes in bacterial community we observed reﬂect the differing abilities of
bacteria to grow under the culture conditions used, and such changes in bacterial
community during a chemostat experiment are widely reported and not unexpected
(17, 21–24, 29). Indeed, analysis using culture-independent methods, as performed in
our study, is more likely to reveal these changes, since it provides much greater insight
into microbial communities present in chemostat models than that offered by many
other methods that have been used to examine chemostat bacterial populations, such
as short-chain fatty acid production, detection of selected bacterial taxa by culture or
PCR, ﬂuorescence in situ hybridization, and qualitative methods such as denaturing
gradient gel electrophoresis (18). We believe that the methods mentioned above do
not provide a sufﬁciently accurate and detailed picture of the microbiota, which will
emerge as more studies of in vitro gut models use culture-independent methods to
understand the true diversity of microbial communities present in their models. Nev-
ertheless, despite some changes seen in their microbial communities, these models will
remain an invaluable and ethical tool which can be used as an effective surrogate to
systematically investigate “real-life” scenarios, such as consequences of infection of
the chicken with MDR Salmonella using controlled experimental models, and for the
ensuing study of interventions that may affect the chicken microbiota. Importantly, the
scenario modeled in our experiment has wider implications, as it provides insight not
only into dissemination of an MDR plasmid from a pathogen to a commensal within the
chicken microbiota, but possibly in any gut environment.
A limitation of all gut models is the recognition that many bacterial species have
fastidious growth requirements that can be difﬁcult to replicate in vitro (3, 4, 18), hence
some differences between the inoculating ceca and the bacteria within the chemostat
vessels is expected. Also, there is considerable variability and diversity in nature, as has
been reported for the in vivo chicken microbiota (3, 4, 28, 30), even from chickens
reared under strictly controlled conditions (31), so some variability is expected between
batches of inoculating ceca. Finally, culture-independent metagenomic studies have
repeatedly demonstrated that microbial diversity is highly variable over time, between
populations, and due to inﬂuences from the external environment (e.g., diet), defying
the concept of a stable core (32).
In this study, the model was used to examine how the chicken cecal microbiota
responds to invasion by the zoonotic pathogen Salmonella enterica serovar Typhimu-
rium and the impact of antibiotic administration. The results closely parallel those seen
in studies performed in vivo, which further validate the use of this model to study such
scenarios. For example, administration of cefotaxime to the model resulted in signiﬁ-
cant decreases in alpha diversity, an effect commonly reported for antibiotic adminis-
tration and observed in vivo in chickens administered penicillin (9), tetracycline (7), or
streptomycin (7), in rats administered cefotaxime (10), and in humans administered
antibiotics, including beta-lactams (11). Also, inoculation of Salmonella into the model
had no signiﬁcant impact on bacterial diversity or community composition, except an
increase in one OTU assigned to the family Peptostreptococcaceae. Importantly, these
results parallel the results of studies of newly hatched chicks (33, 34) and 16-week-old
laying hens (35) which have shown that infection with Salmonella enterica serovar
Enteritidis induces minor but not signiﬁcant alterations to the composition of the
microbiota. One study with young chicks (36), however, reported that infection with
S. Enteritidis signiﬁcantly reduced microbial diversity. Interestingly, that study noted a
concomitant signiﬁcant increase in the abundance of several bacterial groups, includ-
ing the family Peptostreptococcaceae (36).
We observed an increase in enterococci following cefotaxime administration by
both culture (Fig. 3b) and microbial proﬁle (see Table S4 in the supplemental material).
Similarly, M. V. Tulstrup et al. (10) reported a signiﬁcant increase in Enterococcaceae in
the ilea and ceca of rats following cefotaxime treatment. Enterococci have intrinsic
resistance to cephalosporins (37) and would be unaffected by the concentration of
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cefotaxime administered (20 mg/liter) in this study. Therefore, the observed increase is
likely to be a consequence of selection of enterococci over other members of the ﬂora,
which were sensitive to cefotaxime. Enterococci remained at high abundance after
antibiotic administration had ceased, suggesting a potential for a longer term alteration
in the microbiota as a consequence of antibiotic administration. The importance of
such “collateral effects” of antibiotics on the wider microbiota are becoming increas-
ingly recognized (6). For example, we have reported that ciproﬂoxacin administration
in humans leads to an increase in ciproﬂoxacin-resistant Veillonella in the saliva that is
sustained for 12 months (5).
The spread of antibiotic resistance determinants by plasmids presents a signiﬁcant
risk to public and animal health (13, 14). In this study, we have used the gut model to
demonstrate the transfer of a plasmid harboring multidrug resistance from a Salmonella
isolate to commensal E. coli naturally resident in healthy chicken ceca; this model may
possibly replicate the on-farm scenario (15) and those encountered in other animals or
even the human gut. The plasmid transfer rate of 109 to 1010 was high relative to the
established values of 109 to 1018 (26, 38) and occurred in all four vessels inoculated
with Salmonella in two replicate experiments, irrespective of cefotaxime administration.
By employing the chemostat system for 8 days, rather than shorter periods used for
some in vitro models (reviewed in references 18 and 19), we were able to demonstrate
a consistent and reproducible plasmid transfer response within this time frame. Using
an in vitro human cecum model, A. Smet et al. (17) demonstrated the transfer of a
plasmid carrying an ESBL gene from avian to human E. coli in both the presence and
absence of cefotaxime, at transfer rates with the same order of magnitude as we report
here.
Plasmid transfer rates are classically measured in vitro using pure cultures of donor
and recipient at high cell densities (27). However, pure culture conditions do not
accurately reproduce the bacterial communities in the gut of an animal host. Indeed,
transfer rates can be considerably higher in heterogeneous bacterial communities (39).
Another advantage of our model is that it comprised a diverse mixture of bacteria that
sufﬁciently recreates the gut microbiota encountered in vivo so that neither bacterial
donors nor recipients are dominant members. However, the model does not provide an
exact facsimile of the cecum, and plasmid transfer can occur at a higher rate in
well-mixed liquid cultures, such as that used in the model, than in animal intestines (17,
38), although others have reported higher rates in the gut than in vitro (40, 41). Another
consideration when using this model is the absence of any contribution from the host,
such as provision of cellular attachment sites, inﬂammatory responses, which can
contribute to an increase of plasmid transfer (42), or secretion of factors that can reduce
bacterial conjugation, as has been observed with Caco-2 cells (43). The development of
in vitro gut models that enable the coculture of human and microbial cells shows
promise, but to date, only cultures containing one or two bacterial species have been
assessed (44, 45), and their capacity to maintain the complex microbiota of the gut
remains unreported.
The multidrug resistance plasmid pIFM3844 transferred to seven of the nine E. coli
clones identiﬁed in the chicken microbiota, considerably more than the two strains
reported by A. Smet et al. (17). E. coli transconjugants harboring pIFM3844 persisted in
the bacterial community until the end of the experiments on day 8, suggesting a low
or negligible ﬁtness cost to carrying the plasmid in this system, even in the absence of
selection by antibiotic, as has been postulated previously (46).
Acquisition of multidrug-resistant plasmids with low ﬁtness costs and high transfer
rates by commensal bacteria in the chicken gut represents a manifest risk for the
maintenance and dissemination of resistance in the food chain. Indeed, we observed
plasmid transfer within 3 days, suggesting that a transient infection may be sufﬁcient
for plasmid dissemination to commensal bacteria. Furthermore, commensals have the
potential to persist on farms, as they can reside within host animals, and in the
environment, following excretion in feces. Additionally, wildlife such as rodents, which
can be a signiﬁcant reservoir of Salmonella on many poultry farms (47), may be
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colonized by multidrug-resistant commensals, further aiding the maintenance and
dissemination of resistance in the environment. Once established in the commensal
microbiota, the multidrug resistance plasmid can remain available for subsequent
acquisition by pathogens following infection. This presents a potential risk for animal
and public health, as treatment options may be limited if resistant zoonotic pathogens
enter the food chain. Therefore, the in vitro gut model we describe, although not an
exact facsimile of the gut, nevertheless provides a powerful and complex screening tool
to assess and reﬁne interventions that may serve to mitigate the spread of antibiotic
resistance in the gut environment, such as synthetic fatty acids (66) or phage proteins
(67). Furthermore, this system enables such controlled experimental in vitro studies to
be undertaken before employing costly in vivo studies using higher animals and can
help reduce the number of animals used for experiments.
In conclusion, the in vitro gut model we describe provides a valuable approximation
of chicken cecal microbial diversity that enables investigation of the impact of coloni-
zation by a multidrug-resistant zoonotic pathogen and antibiotic administration. In
particular, the model provides insight and demonstration into the dynamics of plasmid
transfer and dissemination of antibiotic resistance to multiple commensal gut E. coli
strains, which can be used to inform risk models studying dissemination of antibiotic
resistance in bacteria from animals.
MATERIALS AND METHODS
Single-stage chemostat fermentation. A parallel chemostat system comprising up to six single-
stage fermentation vessels (20-ml culture volume) was used for the maintenance of the chicken cecal
microbiota. The pH was maintained with an automatic pH controller (Fermac 260; Electrolab Biotech
Limited, UK) at pH 5.8 to 6.0 to simulate the cecal pH, and the temperature was maintained at 41°C using
a circulating water bath to maintain chicken body temperature. Anaerobic conditions, present in the gut,
were maintained by continuous sparging with anaerobic gas mixture (80% N2, 10% CO2, and 10% H2) and
continuously mixed with a magnetic ﬂea. The chemostats were employed as single-stage closed
fermentation vessels for the ﬁrst 24 h after which continuous ﬂow was started by adding fresh
Viande-Leuvre culture medium (21) (ﬂushed with anaerobic gas mixture) into the system with a
peristaltic pump (VSPP; Electrolab Biotech Limited, UK) at a rate of 1.25 ml/h. Experiments were run for
8 days.
Cecal contents were recovered from the carcasses of 6-week-old White Leghorn chickens hatched
from the eggs of speciﬁc-pathogen-free birds (Lohmann, Germany) and housed under experimental
conditions in biosecure facilities. Chickens were reared on standard, nonmedicated chick feed (Lillico
Attlee, UK) and provided with water ad libitum. The birds were obtained as carcasses on the day of
slaughter. No regulated procedures were undertaken as part of this study, and therefore, no ethical
approval was required.
For each experiment, cecal contents from ﬁve birds were pooled and mixed in an anaerobic cabinet
with prereduced 0.1 M phosphate-buffered saline (PBS) (pH 7.2) at a ratio of 40:60 (vol/wt) (PBS-cecal
contents) to create a slurry. For each vessel, 2 ml of this slurry was seeded into 18 ml of Viande-Leuvre
culture medium. Cecal slurry was also used for quantitative bacteriology and stored at 20°C for
subsequent DNA extraction. Samples (2 ml) were collected at 1- or 2-day intervals from each culture
vessel and used for quantitative bacteriology, while 1 ml was centrifuged, with the subsequent cell pellet
stored at 20°C in glycerol-PBS (50:50 [vol/vol]).
The monophasic S. Typhimurium isolate B3844 harboring plasmid pIFM3844, which carries the AMR
genes blaCTX-M1, sul2, and ﬂoR (15), was employed to simulate colonization by a multidrug-resistant
S. Typhimurium. To prepare cultures for inoculation into the gut model, strain B3844 was grown
overnight in Luria-Bertani broth at 37°C with shaking at 300 rpm.
Four experiments were performed. Experiment 1 employed a single vessel seeded with cecal
contents. Experiment 2 employed two vessels; cefotaxime (CTX) (Sigma, Gillingham, UK) was adminis-
tered to one vessel on days 2 and 3, after the daily sample collection, at a ﬁnal concentration of
20 mg/liter, in accordance with previous gut model experiments (20). Experiments 3 and 4 employed six
vessels, which were divided into pairs as follows: two vessels received no Salmonella, two were
inoculated with ~107 CFU Salmonella at hour 0 (i.e., immediately after addition of the cecal slurry), and
two were inoculated with ~107 CFU Salmonella at 21 h after inoculation. The inoculating dose admin-
istered was determined by plating serial dilutions of the inoculum on LB agar. Cefotaxime was admin-
istered to three vessels in each experiment, one vessel of each pair, on days 2 and 3, to a ﬁnal
concentration of 20 mg/liter.
Microbial proﬁling. DNA was extracted from the cell pellets using the Gentra Puregene Yeast/Bact.
kit (Qiagen, Crawley, UK). The cecal slurry was centrifuged and then washed three times with 0.1 M PBS
(pH 7.2) before extraction. For each DNA preparation, the V4 and V5 regions of the 16S rRNA gene were
ampliﬁed using bar-coded primers and sequenced by 454 pyrosequencing using the Roche 454 GS-FLX
system, as described previously (48). The 16S rRNA sequence data were analyzed in the QIIME pipeline
version 1.9.1 (25) installed on BioLinux 8 (49). AmpliconNoise was used for demultiplexing, denoising,
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and removing chimeras (50). Sequences were clustered into operational taxonomic units (OTUs) using
UCLUST (51) with a 97% sequence identity threshold. Reads were aligned to the Greengenes core
reference alignment (52) using PyNAST (53), and taxonomy was assigned with the Ribosomal Database
Project classiﬁer (minimum conﬁdence of 80%) (54). FastTree was used for phylogenetic tree construction
(55). Based on the number of sequences obtained per sample, the relative OTU abundance for each
sample was determined at an even depth of 999 sequences per sample (randomly picked without
replacement; singleton OTUs were excluded from this analysis), which was sufﬁcient to describe the
bacterial community (21).
The microbial proﬁles from all gut model experiments and the corresponding cecal samples were
analyzed together, and the data were structured to allow comparison by time point, cefotaxime
administration, Salmonella inoculation, and experiment number. The Chao1 and Shannon alpha diversity
indices were calculated using QIIME, and signiﬁcant differences (P  0.05) for the categorical variables
were calculated in GraphPad Prism using the Mann-Whitney (two-tailed) test (cefotaxime administration)
and the Kruskal-Wallis test (time point, Salmonella inoculation, and experiment number). Beta diversity
was calculated using UniFrac (56), and the nonparametric statistical method Adonis (25) was employed
with 999 permutations to identify signiﬁcant differences (P  0.05) for the four variables using the
weighted UniFrac distance matrix and both P and R2 values were reported. Three-dimensional principal-
coordinate analysis plots of the weighted UniFrac distance matrix were visualized using EMPeror (57). To
identify OTUs differing in abundance by these variables, the Mann-Whitney test (cefotaxime adminis-
tration) or Kruskal-Wallis test (time point, Salmonella inoculation and experiment number) were used in
QIIME (25), and OTUs with a P value of 0.05 (after Bonferroni’s correction for multiple tests) were
classiﬁed as being signiﬁcantly different.
Quantitative bacteriology. Quantitative bacteriology was performed for experiments 2, 3, and 4
using the method of Miles et al. (58), in which a 10-fold dilution series of the cecal inoculum and aliquots
from gut model cultures were prepared in 0.1 M PBS (pH 7.2). Dilutions were plated onto Brilliance UTI
(urinary tract infection) agar (Oxoid Limited, Basingstoke, UK) with or without cefotaxime (1 g/ml,
recommended by EUCAST [59] as the appropriate screening concentration for isolates that are ESBL
producers) for enumeration of total presumptive E. coli and enterococci and to screen for presumptive
ESBL-producing E. coli, identiﬁed by their chromogenic properties on plates containing cefotaxime.
Presumptive Salmonella and E. coli, identiﬁed by their chromogenic properties on Rambach agar (Oxoid
Limited, Basingstoke, UK) supplemented with 1 g/ml cefotaxime, were also enumerated. Additionally,
the cecal slurry used to seed the vessels was examined for Salmonella on Rambach agar without
cefotaxime. Bacterial counts were analyzed using GraphPad Prism (version 6.04; GraphPad Software, Inc.).
Plasmid transfer rates via bacterial conjugation were calculated using the endpoint method of L.
Simonsen et al. (26). The counts of total Salmonella (donors), total E. coli (recipients), and cefotaxime-
resistant E. coli on Rambach plates (transconjugants) were used. An estimated exponential-phase growth
rate of 2.2 was used for these calculations, based on the data presented by L. Simonsen et al. (26) on the
growth rate of E. coli at 40°C.
Isolate recovery, PCR, and whole-genome sequencing. Representative isolates presumptively
identiﬁed as E. coli, Salmonella, or Enterococcus were subcultured to purity and then identiﬁed to the
species level by MALDI-TOF MS (60). DNA extracts were prepared from these isolates using Prepman Ultra
(Life Technologies, Inc.) from overnight culture at 37°C on blood agar. The presence of blaCTX-M1 and
plasmid pIFM3844 was determined by PCR using published primers (15, 61). DNA was extracted from
selected isolates using the DNeasy kit (Qiagen, Crawley, UK) and Nextera XT libraries prepared for
whole-genome sequencing (WGS) (Illumina, Lesser Chesterford, UK) sequenced on an Illumina MiSeq
platform v2 using 2  250 bp paired-end protocol.
Analysis of whole-genome sequences. For each sequenced isolate, the raw sequences were ﬁltered
and trimmed using Trimmomatic (62), with the parameters for the minimum quality threshold equal to
20, a sliding window equal to 10, and a minimum sequence length equal to 36. The raw trimmed and
ﬁltered data were mapped onto the genome of the reference E. coli K-12 (GenBank accession number
U00096) using SMALT (Sanger Institute). The published genomes of 12 E. coli isolates from poultry
comprising commensal, ESBL-harboring, or avian pathogenic E. coli (APEC) isolates (see Table S7 in the
supplemental material) were also mapped to E. coli K-12. Single nucleotide polymorphisms (SNPs) with
respect to E. coli K-12 were calculated using SAMTOOLS software (63, 64). SNPs were ﬁltered using the
quality thresholds of minimum coverage equal to 4, minimum proportion of raw sequences agreeing
with the SNP call equal to 80%, and SAMTOOLS SNP quality score of 150. A maximum likelihood
phylogenetic tree using the SNPs located within regions present for all the strains was constructed using
RAxML (65).
The antimicrobial resistance (AMR) gene content of the isolates was assessed using SeqFinder, as
described previously (27). Isolate sequence type (ST) was determined by extracting the seven house-
keeping genes of the Achtman multilocus sequence type (MLST) scheme (adk, fumC, gyrB, icd,mdh, purA,
and recA) and interrogation of the PubMLST database (http://pubmlst.org/mlst/).
Accession number(s). The 16S rRNA sequences and whole-genome sequences were deposited in
the European Nucleotide Archive under study accession number PRJEB18652.
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